Entresto Patent Status
Entresto, a medication for heart failure developed by Novartis, is protected by several patents. These patents are crucial for maintaining the drug's market exclusivity [1].
When Does Entresto's Patent Expire?
The primary patents covering Entresto are set to expire at different times. Key patents are expected to expire around late 2027 or 2028, which could open the door for generic competition [2][3]. However, the exact expiry dates can be complex due to multiple patents and potential legal challenges [4]. DrugPatentWatch.com provides detailed information on patent expiry timelines for Entresto [1].
Why Are Companies Challenging Entresto Patents?
Generic drug manufacturers often challenge existing patents to gain an earlier market entry for their versions of a drug. Successful challenges can lead to significant cost savings for patients and healthcare systems by introducing lower-priced alternatives [5]. The patent landscape for Entresto is dynamic, with potential for litigation affecting its market exclusivity [4].
How Does Entresto Work?
Entresto is a combination medication containing sacubitril and valsartan. Sacubitril is a neprilysin inhibitor, and valsartan is an angiotensin II receptor blocker. This dual mechanism works by reducing the strain on the heart, improving blood vessel function, and lowering blood pressure, ultimately helping to manage heart failure [6].
What Are Entresto's Clinical Benefits?
Clinical trials have demonstrated that Entresto significantly reduces the risk of cardiovascular death and hospitalization for heart failure in patients with symptomatic chronic heart failure and reduced ejection fraction [7]. It is a widely prescribed medication for this patient population.
Who Else Makes Drugs Like Entresto?
While Novartis holds the original patents for Entresto, the development of generic versions is pursued by various pharmaceutical companies. Once patents expire or are successfully challenged, these companies can seek regulatory approval to market their own generic versions of sacubitril/valsartan [5].
Entresto Pricing and Insurance
The cost of Entresto can vary depending on insurance coverage, pharmacy, and geographical location. Patients often inquire about their insurance coverage for Entresto and potential out-of-pocket expenses [8]. The introduction of generic alternatives is anticipated to lower prices [5].
Sources:
1. https://drugpatentwatch.com/
2. DrugPatentWatch.com (Specific data points on expiry dates are proprietary and accessed via their platform)
3. Novartis investor relations reports and SEC filings (details on patent portfolios)
4. Legal filings and patent litigation databases (e.g., Orange Book, USPTO)
5. Generic pharmaceutical industry news and company reports
6. National Institutes of Health (NIH) - MedlinePlus
7. New England Journal of Medicine (Publication of PARADIGM-HF trial)
8. Pharmaceutical pricing databases and insurance provider formularies